FindTrial
Sign In

To evaluate the efficacy of lajjalu taila in uterine prolapse

Pharmaceutico-analytical and clinical study to evaluate the efficacy of lajjalu taila in uterine prolapse

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048677
Enrollment
10
Registered
2023-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N812- Incomplete uterovaginal prolapse

Interventions

None listed

Sponsors

Shri BMK Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: First Degree Uterine Prolapse with Subjective Symptoms Second Degree Uterine Prolapse with Subjective Symptoms First Degree Uterine Prolapse with Urethrocele or Rectocele or Cystocele Second Degree Uterine Prolapse with Urethrocele or Rectocele or Cystocele Urethrocele or Rectocele or cystocele

Exclusion criteria

Exclusion criteria: Third degree uterine prolapse with or without decubitus ulcer Vault prolapses Cysto-urethrocele Recent history of exposure to cytotoxic drugs or pelvic radiation therapy K/C/O Sexually transmitted diseases Subjects with known cases of congenital anomalies and carcinoma of reproductive tract Patients with other major systematic disorders which interfere with the treatment

Design outcomes

Primary

MeasureTime frame
There will be significant effect of Lajjalu taila in Uterine ProlapseTimepoint: 0th, 5th, 35th and 70th Days—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Rajeshwari V Kamat

KAHERs Shri BMK Ayurveda Mahavidyalaya

drrajeshwarikamat@gmail.com9449107481

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026